logo
Thousands of customers SWEAR by this brand for problem skin and breakouts - here's why

Thousands of customers SWEAR by this brand for problem skin and breakouts - here's why

Daily Mail​16-05-2025
Multi-award-winning skincare brand 47 skin has dubbed as a 'miracle' for problem skin, racking up thousands of five-star reviews from thrilled customers.
On a mission to share its 'secret ingredient' to as many people suffering from spots and breakouts as possible, what started as a gift from founder Nic Taylor's grandmother has since snowballed into one of the UK's fastest-growing beauty brands.
47 Skin 3-Step Treatment Bundle
This bestselling 3-step bundle has been hailed as a 'miracle' by those with problem skin, said to visibly reduce blemishes in as little as one week of use.
Enriched with Silver Chitoderm®, which actively kills bacteria on the surface of the skin, skin is left feeling fresh, smooth and hydrated, and future breakouts are prevented.
£74 (save £8) Shop
After struggling with blemishes for more than 10 years, Nic was shocked when his skin started to clear up within days (for the first time in a decade).
The pot contained the beginnings of what is now known as Silver Chitoderm®, the unique ingredient that makes 47 Skin so effective for so many people - even when nothing else has helped previously.
Exclusive to the 47 Skin brand, the unique formula of silver and Chitoderm work to form an invisible barrier over the skin, in turn killing bacteria, reducing the appearance of stubborn marks and locking in hydration (making it the perfect choice for combination, blemish-prone skin types).
Dermatologist-approved and clinically tested, each of 47 Skin's products contains the 'miracle' ingredient, which aids in brightening skin tone, reducing fine lines and helping to clear spots and blemishes with continued use.
Its 3 Step Treatment bundle (which is currently on offer for £74 if you act fast), contains the 47 Skin Everyday Cleanser, Silver Mask and the Anti Blemish and Scar Repair Serum - and it's safe to say customers are obsessed with its results.
'Ive struggled with acne all my life,' said one customer. 'This product has been a game-changer for me. It genuinely does work. It took about eight days for me to really see the benefit, but its been transformational'.
'This is life-changing,' stated a second user. 'I struggled with hormonal acne for nearly a year. NOTHING worked for me, and I'm not exaggerating, within about three days of starting to use this my skin improved. After two weeks I was able to go to work with no makeup on for the first time in months! It's incredible, I wish I tried it sooner'.
'I can't believe this works!', said a third user. 'I have suffered with cystic acne since I was a teenager and it has flared back up in my 40's. When I ordered it I was feeling despondent about my skin as nothing was working, but I was amazed when I started seeing results! In about four weeks my skin was clear. I wouldn't be without this product now, thank you 47 Skin!'.
The only brand in the world to use Silver Chitoderm®, customers have noted a reduction in major skin ailments in as little as three days of using the products - and has built itself a loyal following thanks to incredible before and after pictures.
Deemed as rosacea-safe, as well as suitable for those suffering with ecezma, spots and psoraisis, you can buy the products and learn more about 47 Skin's story here. Hurry - your best skin yet awaits.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Guardian view on regulating cosmetic procedures: rogue operators must be tackled, but aren't the only problem
The Guardian view on regulating cosmetic procedures: rogue operators must be tackled, but aren't the only problem

The Guardian

time42 minutes ago

  • The Guardian

The Guardian view on regulating cosmetic procedures: rogue operators must be tackled, but aren't the only problem

The enormous popularity of beauty treatments, including dermatological fillers and Botox injections, is not solely an issue for health regulators. Changing norms and aspirations about appearances, and the way that these are marketed mainly to women and girls, are a cultural and economic phenomenon that requires wider consideration. While attitudes to these procedures and aesthetics vary, many people – including some cosmetic surgeons – are concerned that younger women account for a growing share of a highly lucrative and growing market. The death last year of 33-year-old Alice Webb in Gloucestershire, after a non-surgical Brazilian butt lift, as well as multiple reports of injuries, and the deaths of at least 28 women who have travelled to Turkey for cosmetic treatments, have increased the pressure on ministers to tighten the law. Wes Streeting's announcement of new licence requirements for UK businesses, and tighter regulation of higher-risk treatments, is probably overdue. The Chartered Trading Standards Institute recently warned that untrained people have given cosmetic injections in public toilets and hotels. Altering the law in order to exclude such 'rogue operators' ought to make high streets and the internet – where many clinics advertise – safer. Talking about the risks, as the health secretary has been doing, and holding a consultation on proposed changes, may have the beneficial effect of raising awareness even before changes are introduced. But councils will need resources if they are to be expected to enforce new rules by issuing licences, checking premises and so on. As in many other areas of economic activity, the law on its own is unlikely to be enough. Mechanisms are needed to ensure that businesses comply. It is already illegal to administer Botox or dermal fillers to children in England – although, worryingly, it is still allowed in Wales and Scotland. Mr Streeting's announcement that rules regarding children will be tightened further is particularly welcome. Strenuous efforts should be made to place them off limits for the industry as a whole. The reported preoccupation of some children with anti-ageing products is not healthy and should be discouraged. Mr Streeting did not refer to the cost to the NHS if cosmetic procedures go wrong, when announcing plans to tighten the law. But Karin Smyth, one of his ministers, has raised this. And Prof Sir Stephen Powis, who was NHS England's national medical director until last month, made the same point specifically in relation to butt lifts – the cosmetic procedure with the highest death rate of all. Ministers should expect pushback even though many experts, including plastic surgeons, favour tighter rules. The pro-growth mood of the Treasury means proposals for new regulations are unlikely to be smiled upon there. The more restrictive approach being proposed for England will also do nothing to prevent surgical tourism and could even increase it, if tighter regulation of the domestic industry results in higher prices. The gap in safeguards that allows foreign cosmetic surgery providers to market directly to the public needs to be addressed separately, which the government has begun to recognise. There is no single or instant fix. But by cracking down on cowboy operators, ministers will send a message that appearance-altering injections and other invasive treatments must be treated seriously. They are a different order of activity from applying makeup or painting nails. Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here.

Obese to get soups and shakes diet instead of weight-loss jabs
Obese to get soups and shakes diet instead of weight-loss jabs

Times

time2 hours ago

  • Times

Obese to get soups and shakes diet instead of weight-loss jabs

Low-calorie soups and shakes are to be prescribed to thousands of overweight people in Scotland in an attempt to reduce their dependence on expensive weight-loss drugs and provide longer-lasting health benefits. From January, 3,000 patients who have been newly diagnosed with type 2 diabetes will be recruited for a clinical trial. About 300,000 Scots live with type 2 diabetes, a condition commonly linked to obesity, in which badly regulated blood sugar levels can increase the risk of heart disease, kidney disease, strokes or nerve conditions. About 10,000 of them are being treated with weight-loss drugs such as Ozempic, Wegovy and Mounjaro, with injections costing the NHS £3,000 a year. The estimated annual bill of £30 million is expected to rise as manufacturers raise prices. NHS chiefs believe that not only will the soups and shakes plan be less expensive, it will also bring longer-term health benefits. In the Total Diet Replacement (TDR) plan, to be rolled out over three years, patients who have recently been diagnosed with type 2 diabetes and are deemed eligible will be given low-calorie substitutes for their breakfast, lunch and dinner. The replacement meals, containing a maximum of 900 calories a day, will be delivered to patients for between three and five months. • What to do now Mounjaro's hiking its prices, by an obesity expert After this initial period, normal food will be reintroduced, but with guidance given on healthy meals through online consultations and an app. The ambition is for patients to lose up to 10 per cent of their body weight over a year. Doctors are also optimistic that up to 40 per cent of the trial participants will achieve remission from type 2 diabetes within a year. There are fears that the weight lost through injections — which work by suppressing the appetite — may last only as long as the patient is taking the drug. By contrast, the effects of diet changes should prove more long-lasting and cost effective, NHS officials believe. The TDR scheme is set to cost £5.6 million for 3,000 patients, a one-off cost of about £1,866 per person. Doctors hope the plan will help patients to fundamentally alter their diet and lifestyle. A spokesman for the Scottish government said: 'We anticipate that around 35 to 40 per cent will achieve remission from type 2 diabetes at the end of their first year on the programme, with a majority of patients benefiting from a clinically significant average weight loss of 10 per cent.' This would lead to reductions in blood pressure and contribute to a reduced risk of cardiovascular disease. He added: 'We will measure impact by the number of patients recruited into this programme, the number who achieve remission and the number with clinically significant weight loss.'

The Guardian view on regulating cosmetic procedures: rogue operators must be tackled, but aren't the only problem
The Guardian view on regulating cosmetic procedures: rogue operators must be tackled, but aren't the only problem

The Guardian

time3 hours ago

  • The Guardian

The Guardian view on regulating cosmetic procedures: rogue operators must be tackled, but aren't the only problem

The enormous popularity of beauty treatments, including dermatological fillers and Botox injections, is not solely an issue for health regulators. Changing norms and aspirations about appearances, and the way that these are marketed mainly to women and girls, are a cultural and economic phenomenon that requires wider consideration. While attitudes to these procedures and aesthetics vary, many people – including some cosmetic surgeons – are concerned that younger women account for a growing share of a highly lucrative and growing market. The death last year of 33-year-old Alice Webb in Gloucestershire, after a non-surgical Brazilian butt lift, as well as multiple reports of injuries, and the deaths of at least 28 women who have travelled to Turkey for cosmetic treatments, have increased the pressure on ministers to tighten the law. Wes Streeting's announcement of new licence requirements for UK businesses, and tighter regulation of higher-risk treatments, is probably overdue. The Chartered Trading Standards Institute recently warned that untrained people have given cosmetic injections in public toilets and hotels. Altering the law in order to exclude such 'rogue operators' ought to make high streets and the internet – where many clinics advertise – safer. Talking about the risks, as the health secretary has been doing, and holding a consultation on proposed changes, may have the beneficial effect of raising awareness even before changes are introduced. But councils will need resources if they are to be expected to enforce new rules by issuing licences, checking premises and so on. As in many other areas of economic activity, the law on its own is unlikely to be enough. Mechanisms are needed to ensure that businesses comply. It is already illegal to administer Botox or dermal fillers to children in England – although, worryingly, it is still allowed in Wales and Scotland. Mr Streeting's announcement that rules regarding children will be tightened further is particularly welcome. Strenuous efforts should be made to place them off limits for the industry as a whole. The reported preoccupation of some children with anti-ageing products is not healthy and should be discouraged. Mr Streeting did not refer to the cost to the NHS if cosmetic procedures go wrong, when announcing plans to tighten the law. But Karin Smyth, one of his ministers, has raised this. And Prof Sir Stephen Powis, who was NHS England's national medical director until last month, made the same point specifically in relation to butt lifts – the cosmetic procedure with the highest death rate of all. Ministers should expect pushback even though many experts, including plastic surgeons, favour tighter rules. The pro-growth mood of the Treasury means proposals for new regulations are unlikely to be smiled upon there. The more restrictive approach being proposed for England will also do nothing to prevent surgical tourism and could even increase it, if tighter regulation of the domestic industry results in higher prices. The gap in safeguards that allows foreign cosmetic surgery providers to market directly to the public needs to be addressed separately, which the government has begun to recognise. There is no single or instant fix. But by cracking down on cowboy operators, ministers will send a message that appearance-altering injections and other invasive treatments must be treated seriously. They are a different order of activity from applying makeup or painting nails. Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store